Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 01-2018 | 01-2017 | 01-2016 | 01-2015 | 01-2014 | |
| Sales | 5,279 | 6,621 | 6,040 | 5,376 | 5,964 |
| Cost of Goods | 3,984 | 4,804 | 4,588 | 4,138 | 4,516 |
| Gross Profit | 1,295 | 1,817 | 1,453 | 1,238 | 1,448 |
| Operating Expenses | 1,706 | 1,633 | 1,498 | 1,087 | 1,433 |
| Operating Income | 573 | 988 | 542 | 289 | 531 |
| Interest Expense | 34 | 38 | 43 | 59 | 66 |
| Other Income | -58 | -94 | 577 | 353 | 195 |
| Pre-tax Income | 482 | 856 | 1,076 | 583 | 660 |
| Income Tax | 34 | 187 | -201 | 5 | 1 |
| Net Income Continuous | 448 | 669 | 1,278 | 578 | 659 |
| Net Income | $448 | $669 | $1,278 | $578 | $659 |
| EPS Basic Total Ops | 0.13 | 0.20 | 0.38 | 0.17 | 0.21 |
| EPS Basic Continuous Ops | 0.13 | 0.20 | 0.38 | 0.18 | 0.21 |
| EPS Diluted Total Ops | 0.13 | 0.19 | 0.37 | 0.16 | 0.20 |
| EPS Diluted Continuous Ops | 0.13 | 0.19 | 0.37 | 0.17 | 0.20 |
| EPS Diluted Before Non-Recurring Items | 0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $823 | $1,207 | $745 | $469 | $698 |